Status:
UNKNOWN
Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com
Lead Sponsor:
Amit N. Patel MD MS
Conditions:
Cardiovascular System Diseases (& [Cardiac])
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- U...
Detailed Description
The clinical cell registry includes data on thoracic and cardiovascular diseases including: Acute myocardial infarction, Chronic Angina, Heart Failure, Wound Healing including Sternal, Peripheral Art...
Eligibility Criteria
Inclusion
- Age \>=18 years old
- Approved consent to be enrolled in trial/registry
Exclusion
- Prior malignancy in the 5 years before treatment in this study (other than curatively treated carcinoma in-situ of the cervix or non-melanoma skin cancer)
- Inability or unwillingness to comply with the treatment protocol, follow-up, research tests, or give consent
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00130377
Start Date
August 1 2002
End Date
December 1 2020
Last Update
January 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84132